fMRI Cholinergic Mechanisms in Schizophrenia

NCT01191827 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2015-05-15

Study results available
· View outcomes & findings →

Summary

This study aims to determine how clozapine treatment improves neuronal measures of sensory gating in subjects with schizophrenia.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Jason R. Tregellas, PhD · VA Eastern Colorado Health Care System, Denver

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01191827 on ClinicalTrials.gov